Matthew Davids, MD, MMSc

About Dr. Davids

Dr. Davids is an Associate Professor of Medicine at Harvard Medical School and an attending physician in the Division of Lymphoma at Dana-Farber Cancer Institute, where he serves as Director of Clinical Research and Associate Director of the Chronic Lymphocytic Leukemia (CLL) Center. He obtained his AB cum laude in chemistry from Harvard College and his MD cum laude from Yale University School of Medicine. Dr. Davids completed his internship, residency, and service as assistant chief resident in internal medicine at New York-Presbyterian Weill Cornell Medical Center and Memorial Sloan Kettering Cancer Center. He went on to complete a fellowship in hematology and oncology through Dana-Farber/Partners CancerCare and earned a Master of Medical Sciences (MMSc) from Harvard Medical School. He also attends on the inpatient hematologic malignancies service at Brigham and Women’s Hospital.

Dr. Davids leads a translational research program in CLL and non-Hodgkin lymphoma, with a focus on Bcl-2 biology and apoptosis. His research includes clinical trials investigating novel therapeutic strategies, particularly targeted inhibitors of Bcl-2 and B cell receptor pathway kinases, and the use of checkpoint inhibitors to enhance anti-tumor immunity, especially in the post–allogeneic transplant setting.